Literature DB >> 7129642

Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis.

W L George, R D Rolfe, G K Harding, R Klein, C W Putnam, S M Finegold.   

Abstract

Thirty patients with antimicrobial agent-associated pseudomembranous colitis (PMC) were studied for the presence of Clostridium difficile and its cytotoxin in feces. Either colonoscopy or barium enema radiography was required in three patients for the diagnosis of PMC because of nondiagnostic findings at sigmoidoscopy. Both the organism and cytotoxin were detected in 27 of the 30 patients; Staphylococcus aureus was excluded as the cause of PMC in two of the remaining patients. Eighteen of 19 patients with C. difficile-induced PMC who were treated with oral vancomycin had a salutary response; seven patients, however, had a relapse of colitis following the discontinuation of vancomycin. In general, relapses of colitis responded to retreatment with vancomycin. The implication of C. difficile as a cause of diarrhea is best achieved by the demonstration of colonic mucosal plaques or of a pseudomembrane. The value of fecal culture for C. difficile and cytotoxin assay is limited by the existence of asymptomatic carriers.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7129642     DOI: 10.1007/bf01666910

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  15 in total

1.  Antibiotic associated pseudomembranous colitis with negative proctosigmoidoscopy examination.

Authors:  F J Tedesco
Journal:  Gastroenterology       Date:  1979-08       Impact factor: 22.682

2.  Diagnostic features of clindamycin-associated pseudomembranous colitis.

Authors:  F J Tedesco; R J Stanley; D H Alpers
Journal:  N Engl J Med       Date:  1974-04-11       Impact factor: 91.245

3.  Pseudomembranous colitis after treatment with metronidazole.

Authors:  G Thomson; A H Clark; K Hare; W G Spilg
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-14

4.  Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis.

Authors:  J G Bartlett; F J Tedesco; S Shull; B Lowe; T Chang
Journal:  Gastroenterology       Date:  1980-03       Impact factor: 22.682

5.  Colonoscopy in the diagnosis of antibiotic-associated colitis. A prospective study.

Authors:  K Seppälä; L Hjelt; P Sipponen
Journal:  Scand J Gastroenterol       Date:  1981       Impact factor: 2.423

6.  Clinical and laboratory observations in Clostridium difficile colitis.

Authors:  J G Bartlett; N S Taylor; T Chang; J Dzink
Journal:  Am J Clin Nutr       Date:  1980-11       Impact factor: 7.045

7.  Treatment and prevention of antimicrobial agent-induced colitis and diarrhae.

Authors:  W L George; R D Rolfe; S M Finegold
Journal:  Gastroenterology       Date:  1980-08       Impact factor: 22.682

8.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

Review 9.  Antibiotic-associated pseudomembranous colitis.

Authors:  J G Bartlett
Journal:  Rev Infect Dis       Date:  1979 May-Jun

10.  Diagnosis of pseudomembranous colitis.

Authors:  A Kappas; N Shinagawa; Y Arabi; H Thompson; D Burdon; F Dimock; R H George; J Alexander-Williams; M R Keighley
Journal:  Br Med J       Date:  1978-03-18
View more
  15 in total

1.  A clinical view of vancomycin in 1990.

Authors:  W T Siebert
Journal:  Tex Heart Inst J       Date:  1990

Review 2.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

3.  Fixation of Clostridium difficile toxin A and cholera toxin to intestinal brush border membranes from axenic and conventional mice.

Authors:  F Lucas; G W Elmer; E Brot-Laroche; G Corthier
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

4.  Analysis of proline reduction in the nosocomial pathogen Clostridium difficile.

Authors:  Sarah Jackson; Mary Calos; Andrew Myers; William T Self
Journal:  J Bacteriol       Date:  2006-10-13       Impact factor: 3.490

Review 5.  Rapid detection of Clostridium difficile toxins and laboratory diagnosis of Clostridium difficile infections.

Authors:  Shuyi Chen; Huawei Gu; Chunli Sun; Haiying Wang; Jufang Wang
Journal:  Infection       Date:  2016-09-06       Impact factor: 3.553

Review 6.  Host response to Clostridium difficile infection: Diagnostics and detection.

Authors:  Elena A Usacheva; Jian-P Jin; Lance R Peterson
Journal:  J Glob Antimicrob Resist       Date:  2016-09-20       Impact factor: 4.035

7.  Improvement of Clostridium difficile isolation by heat-shock and typing of the isolated strains by SDS-PAGE.

Authors:  M Lahn; G Tyler; W Däubener; U Hadding
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

8.  Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters.

Authors:  P H Kim; J P Iaconis; R D Rolfe
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

Review 9.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

10.  Suppression by Saccharomyces boulardii of toxigenic Clostridium difficile overgrowth after vancomycin treatment in hamsters.

Authors:  G W Elmer; L V McFarland
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.